SG3 Management, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,531,044
-40.5%
239,600
+77.6%
0.22%
+317.0%
Q4 2021$2,575,000
-53.8%
134,900
-40.3%
0.05%
-68.6%
Q3 2021$5,574,000
+167.7%
226,000
+182.5%
0.17%
+128.4%
Q2 2021$2,082,000
+31.5%
80,000
+60.0%
0.07%
+85.0%
Q1 2021$1,583,000
-86.5%
50,000
-80.2%
0.04%
-82.1%
Q4 2020$11,739,000
+17.7%
253,000
-16.5%
0.22%
-39.6%
Q3 2020$9,975,000
+372.5%
303,000
+294.0%
0.37%
+152.7%
Q2 2020$2,111,000
+1307.3%
76,900
+1438.0%
0.15%
+630.0%
Q1 2020$150,0005,0000.02%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders